Fig. 4: Survival curves of all pediatric AML patients according to the FLT3/ITD AR and SCT status. | Nature Communications

Fig. 4: Survival curves of all pediatric AML patients according to the FLT3/ITD AR and SCT status.

From: Poor outcome of pediatric patients with acute myeloid leukemia harboring high FLT3/ITD allelic ratios

Fig. 4

A Probability of EFS for patients with chemotherapy-only in different FLT3/ITD AR. B Probability of OS for patients with chemotherapy-only in different FLT3/ITD AR. C Probability of EFS for patients with SCT in different FLT3/ITD AR. D Probability of OS for patients with SCT in different FLT3/ITD AR. AML acute myeloid leukemia, SCT stem cell transplantation, AR allelic ratio, EFS event-free survival, OS overall survival. EFS and OS were evaluated by the Kaplan–Meier method and compared by log-rank test. Source data are provided as a Source Data file.

Back to article page